BCL2 and acute myeloid leukemia: The expression of METTL3 has been shown to be increased in acute myeloid leukemia (AML) patients, suppressing cell differentiation and apoptosis, and promoting cell proliferation through increased translation of c-MYC, BCL2, and PTEN.